Latest Price Spikes News

Aguia Resources reports a significant uplift in the economics of its Tres Estrades Phosphate Project in Brazil, driven by soaring phosphate prices and a streamlined production strategy targeting early 2026 start-up.

QuickFee Limited reports a record A$7.2 million quarterly revenue, driven by strong US and Australian growth, alongside positive underlying profitability and a major refinancing.

Podium Minerals has significantly expanded its Parks Reef project with a new Copper-Gold Zone resource, increasing the basket price by 18% and completing a $2.6 million oversubscribed capital raise.

Latrobe Magnesium Limited has addressed ASX concerns over recent share price and volume spikes, attributing the market activity to recognition of its asset value and the imminent start of its demonstration plant.

Advance ZincTek Limited (ASX, ANO) has responded to an ASX price query following a sharp increase in its share price and trading volume, confirming no undisclosed material information and reaffirming compliance with continuous disclosure rules.

Arika Resources has responded to an ASX price query, confirming no undisclosed information behind recent share price movements and highlighting its active drilling program and recent $5 million capital raise.

Resolution Minerals has addressed ASX concerns over recent share price and volume spikes, attributing the activity to ongoing developments in its US Horse Heaven project acquisition.

G50 Corp Limited attributes its recent share price jump to earlier announcements about a new precious metals discovery, confirming no undisclosed information is driving the trading activity.

Raptis Group Limited has confirmed the resignation of director James Raptis effective September 30, 2025, amid a sharp rise in its share price and trading volume. The company denies any other undisclosed information behind the recent market activity.

Australian Rare Earths (ASX, AR3) has responded to an ASX price query, denying any undisclosed price-sensitive information and attributing recent trading activity to sector interest and recent company announcements.

Alterity Therapeutics has responded to an ASX inquiry about its recent share price and volume spike, confirming no undisclosed information but highlighting imminent clinical data releases and investor roadshows as possible drivers.

Castile Resources has integrated bismuth as a by-product into its Rover 1 Bankable Feasibility Study following China’s export restrictions, positioning itself as a key supplier amid global supply shocks. The company also advances exploration with innovative technology and secures strategic partnerships in critical mineral supply chains.